Gastroenterology
Volume 134, Issue 1 , Pages 344-345 , January 2008

Pancreatic Cancer: Cause and Result of Diabetes Mellitus

  • Niels Teich

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Niels Teich, MD, University of Leipzig Medical Clinic II, Gastroenterology and Hepatology, Philipp-Rosenthal-Str. 27, D-04103 Leipzig, Germany. fax: (49) 341 9712209.

References 

  1. Bright R. Cases and observations connected with disease of the pancreas and duodenum. Med Chir Tr. 1833;18:1–56
  2. Poel WE, Yergganian G. Adenocarcinoma of the pancreas in diabetes-prone Chinese hamsters. Am J Med. 1961;31:861–863
  3. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer (A meta-analysis). JAMA. 1995;273:1605–1609
  4. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005;92:2076–2083
  5. Stevens RJ, Roddam AW, Beral V. Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer. 2007;96:507–509
  6. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2007;30:S42–S47
  7. Chari ST, Leibson CL, Rabe KG, et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology. 2008;134:95–101
  8. Basso D, Brigato L, Veronesi A, et al. The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice. Anticancer Res. 1995;15:2585–2588
  9. Fogar P, Pasquali C, Basso D, et al. Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res. 1994;14:2827–2830
  10. Chari ST, Leibson CL, Rabe KG, et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology. 2005;129:504–511
  11. Gupta S, Vittinghoff E, Bertenthal D, et al. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol. 2006;4:1366–1372
  12. Damiano J, Bordier L, Le Berre JP, et al. Should pancreas imaging be recommended in patients over 50 years when diabetes is discovered because of acute symptoms?. Diabetes Metab. 2004;30:203–207
  13. Carpelan-Holmstrom M, Nordling S, Pukkala E, et al. Does anyone survive pancreatic ductal adenocarcinoma? (A nationwide study re-evaluating the data of the Finnish Cancer Registry). Gut. 2005;54:385–387
  14. Permert J, Larsson J, Westermark GT, et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med. 1994;330:313
  15. Basso D, Greco E, Fogar P, et al. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?. Clin Chim Acta. 2006;372:120–128
  16. Absetz P, Valve R, Oldenburg B, et al. Type 2 diabetes prevention in the “real world”: one-year results of the GOAL Implementation Trial. Diabetes Care. 2007;30:2465–2470
  17. Dabelea D, Snell-Bergeon JK, Hartsfield CL, et al. Increasing prevalence of gestational diabetes mellitus (Gdiabetes mellitus) over time and by birth cohort: Kaiser Permanente of Colorado Diabetes Mellitus Screening Program. Diabetes Care. 2005;28:579–584
  18. Perrin MC, Terry MB, Kleinhaus K, et al. Gestational diabetes as a risk factor for pancreatic cancer: A prospective cohort study. BMC Med. 2007;5:25

PII: S0016-5085(07)02033-1

doi: 10.1053/j.gastro.2007.11.020

Gastroenterology
Volume 134, Issue 1 , Pages 344-345 , January 2008

Article Tools